Eli Lilly & Co. (LLY) Removed from US 1 List at BofA/ML
- European stocks hit three-week low as Trump reality sets in
- Unease over Trump sends dollar to one-and-half month low
- Oil eases after two-day gain, rising U.S. production weighs
- Walgreens Boots Alliance (WBA) Said to Face Antitrust Concern for Rite Aid (RAD) Fix - Bloomberg
- Bristol-Myers Squibb (BMY) Says It Won't Pursue Accelerated U.S. Regulatory Pathway for Opdivo Plus Yervoy in Lung Cancer
News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.
Eli Lilly & Co. (NYSE: LLY) Removed from US 1 List at BofA/ML
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Morgan Stanley Downgrades Workiva (WK) to Equalweight, Says Owning The Stock Could be Challenging In 2017
- Checkpoint Software (CHKP) PT Raised to $94 at Stifel Following 4Q Beat
- Morgan Stanley Upgrades TIM Participacoes (TSU) to Overweight
Create E-mail Alert Related CategoriesAnalyst Comments, Downgrades
Related EntitiesBank of America, US 1 List
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!